Predicted to enable GTPase activator activity. Predicted to be located in cytoplasm. Is expressed in several structures, including central nervous system and ganglia. Orthologous to human SMAP2 (small ArfGAP2). [provided by Alliance of Genome Resources, Apr 2022]